Healthcare & Life Sciences
TargED Biopharmaceutical
Netherlandstargedbiopharmaceuticals.com
aliveseries-a
series-a
Stage
About
TargED Biopharmaceuticals develops first-in-class biological drugs using targeted enzyme delivery via small antibodies to treat all types of thrombosis, including immune thrombotic thrombocytopenic purpura and acute ischemic stroke.
Explore TargED Biopharmaceutical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.